EMS is the biggest domestic pharmaceutical company in Brazil.[1] Founded in the mid-1950s, the company has six industrial plants based in São Bernardo do Campo, Hortolândia and Jaguariúna, in the state of São Paulo, Manaus, Brasília and Belgrade in Serbia.
Company type | Private |
---|---|
Industry | Pharmaceuticals |
Founded | 1950 |
Headquarters | Hortolândia, Brazil |
Key people | Waldir Eschberger, (CEO) |
Products | Drugs and generic drug |
Revenue | US$ 1.3 billion (2016) |
Number of employees | 4,500 |
Subsidiaries | Galenika a.d. Brace Pharma |
Website | www.ems.com.br |
EMS operates through five divisions:
- EMS Similars - markets similares; a class of pharmaceuticals peculiar to the Brazilian market. Not generics but not original brands either;
- EMS Generics - markets generics;
- EMS Sigma Pharma - markets branded medicines;
- EMS Hospital - markets drugs to hospitals;
- EMS Consumer - markets OTC drugs.
Today the company has a presence in over 30 countries through joint-ventures and strategic partnerships with other pharmaceutical companies.[2]
EMS's Brazilian main competitors are Hypermarcas, Eurofarma, Aché and Cristália.
References
edit- ^ Focus Reports "Brazil: Big Dancer Takes the Floor" Archived 2011-07-11 at the Wayback Machine Pharmaceutical Executive, October 2007
- ^ "EMS adquire farmacêutica sérvia Galenika". Exame (in Brazilian Portuguese). 2017-11-02. Retrieved 2023-11-01.
External links
edit- (in Portuguese and English) Official website